ClearPoint Neuro, Inc. Common Stock (CLPT) is a publicly traded Healthcare sector company. As of July 22, 2026, CLPT trades at $15.41 with a market cap of $451.34M and a P/E ratio of -21.78. CLPT moved +2.33% today. Year to date, CLPT is +12.65%; over the trailing twelve months it is +40.35%. Its 52-week range spans $8.27 to $30.10. Analyst consensus is strong buy with an average price target of $28.33. Rallies surfaces CLPT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
3 analysts cover CLPT: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $28.33.
| Metric | Value |
|---|---|
| Price | $15.41 |
| Market Cap | $451.34M |
| P/E Ratio | -21.78 |
| EPS | $-0.70 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.10 |
| 52-Week Low | $8.27 |
| Volume | 487.43K |
| Avg Volume | 0 |
| Revenue (TTM) | $31.39M |
| Net Income | $-18.91M |
| Gross Margin | 60.92% |
3 analysts cover CLPT: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $28.33.